These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

913 related articles for article (PubMed ID: 12471050)

  • 1. T cell anergy.
    Schwartz RH
    Annu Rev Immunol; 2003; 21():305-34. PubMed ID: 12471050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation.
    Deeths MJ; Kedl RM; Mescher MF
    J Immunol; 1999 Jul; 163(1):102-10. PubMed ID: 10384105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T:T antigen presentation by activated murine CD8+ T cells induces anergy and apoptosis.
    Chai JG; Bartok I; Scott D; Dyson J; Lechler R
    J Immunol; 1998 Apr; 160(8):3655-65. PubMed ID: 9558065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1.
    Kubsch S; Graulich E; Knop J; Steinbrink K
    Eur J Immunol; 2003 Jul; 33(7):1988-97. PubMed ID: 12884865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.
    Chai JG; Vendetti S; Bartok I; Schoendorf D; Takacs K; Elliott J; Lechler R; Dyson J
    J Immunol; 1999 Aug; 163(3):1298-305. PubMed ID: 10415027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 regulates tolerance induction and T cell differentiation in vivo.
    Walunas TL; Bluestone JA
    J Immunol; 1998 Apr; 160(8):3855-60. PubMed ID: 9558090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
    Frauwirth KA; Alegre ML; Thompson CB
    J Immunol; 2000 Mar; 164(6):2987-93. PubMed ID: 10706686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interleukin 12 and costimulators in T cell anergy in vivo.
    Van Parijs L; Perez VL; Biuckians A; Maki RG; London CA; Abbas AK
    J Exp Med; 1997 Oct; 186(7):1119-28. PubMed ID: 9314560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-blocking agents, alone or in combination with cyclosporin A, induce antigen-specific anergy of human memory T cells.
    Yi-qun Z; Lorré K; de Boer M; Ceuppens JL
    J Immunol; 1997 May; 158(10):4734-40. PubMed ID: 9144487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of CD4 T cell fate by antigen re-stimulation with or without CTLA-4 engagement 24 h after priming.
    Nakata Y; Uzawa A; Suzuki G
    Int Immunol; 2000 Apr; 12(4):459-66. PubMed ID: 10744647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High concentrations of antigenic ligand activate and do not tolerize naive CD4 T cells in the absence of CD28/B7 costimulation.
    Teh HS; Teh SJ
    Cell Immunol; 1997 Jul; 179(1):74-83. PubMed ID: 9259774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism.
    Shrikant P; Khoruts A; Mescher MF
    Immunity; 1999 Oct; 11(4):483-93. PubMed ID: 10549630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of hapten-specific tolerance of human CD8+ urushiol (poison ivy)-reactive T lymphocytes.
    Kalish RS; Wood JA
    J Invest Dermatol; 1997 Mar; 108(3):253-7. PubMed ID: 9036920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
    Ding L; Shevach EM
    Eur J Immunol; 1994 Apr; 24(4):859-66. PubMed ID: 7512033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anergy in peripheral memory CD4(+) T cells induced by low avidity engagement of T cell receptor.
    Mirshahidi S; Huang CT; Sadegh-Nasseri S
    J Exp Med; 2001 Sep; 194(6):719-31. PubMed ID: 11560989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
    Lane P; Haller C; McConnell F
    Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.